1. Insights
  2. News
  3. Press Releases

Akin Advises Pharmakon Advisors on CHF 250 Million Term Loan to Idorsia Ltd

June 26, 2026

Reading Time : 1 min
Jump to
View People Mentioned in This NewsView Related Services, Sectors, and Regions

Contact:

Alexandra Field

Director of Communications

Send Email
+1 212.407.3167

Roseanne Green

Senior Communications Manager

Send Email
+44 20.7661.5408

(New York) – Akin advised Pharmakon Advisors, LP, a leading investor in non-dilutive debt for the life sciences industry and the investment manager for the BioPharma Credit funds, and the BioPharma Credit Funds in connection with an up to CHF 250 million senior secured term loan to Idorsia Ltd, with the first tranche of CHF 105 million funded at closing. Idorsia Ltd is a leading, commercial-stage biopharmaceutical company with a portfolio of first- or best-in-class assets, focused on discovering, developing, and commercializing innovative medicines to help more patients.   

The Akin team was led by tax partner Geoffrey Secol and included fellow tax partners Stuart Leblang and David Snyder and associate John Kwack; international trade partner Nnedinma Ifudu Nweke; health care & life sciences partner Nate Brown and senior counsel Jo-Ellyn Klein; environment & natural resources senior counsel Andrew Oelz; executive compensation & employee benefits senior counsel Michael Roebuck; finance senior counsel Brian Albert; and corporate associates Jake Gawlak and Yossi Abadi.    

For additional information on the transaction, please click here.     

Akin is a leading international law firm with more than 1,000 lawyers in offices throughout the United States, Europe, and the Middle East.   

### 

Share This Insight

Related Services, Sectors, and Regions

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.